Variational AI is a company that uses generative AI for drug discovery, creating novel small molecules to expedite drug development.

The Enki™ platform utilizes advanced generative AI to generate and optimize novel drug-like small molecules suitable for various therapeutic targets.

Pharmaceutical companies, biotechnology firms, research institutions, and drug discovery professionals can benefit from Variational AI’s services.

Generative AI accelerates drug discovery, reduces development costs, enhances molecule diversity, and increases the likelihood of effective treatment discovery.

Yes, Variational AI collaborates closely with biopharmaceutical companies for drug development projects.

Enki™ can generate novel and diverse drug-like small molecules optimized for multiple properties.

Yes, Variational AI has ongoing projects with pharmaceutical companies such as Merck to evaluate their Enki™ platform.

Variational AI uses data-efficient modeling and multi-property optimization to ensure the effectiveness of generated molecules.

Variational AI is based in Vancouver, Canada.

You can contact Variational AI through their website or support email for inquiries and collaboration opportunities.